Previous 10 | Next 10 |
ClearPoint Neuro (CLPT) is set to join Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28.ClearPoint Neuro’s membership in the US all-cap Russell 3000 Index, which remains in place for one year, wi...
SOLANA BEACH, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, is set to join the broad-market Russell 3000 Index at the conclusion of the...
SOLANA BEACH, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates BlueRock Therapeutics, a clinical stage biopharmaceutic...
The following slide deck was published by ClearPoint Neuro, Inc. in conjunction with this event. For further details see: Clearpoint Neuro (CLPT) Investor Presentation - Slideshow
SOLANA BEACH, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the UBS Global Healthcar...
ClearPoint Neuro (CLPT) announced a group of neurosurgeons has used its SmartFrame Array Neuro Navigation System and Software for the first time in human cases.The Array system is designed to speed up neurosurgeries enabling surgeons to complete three neurosurgical procedures using ...
SOLANA BEACH, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling company providing navigation and delivery to the brain, today announced the first human cases of the SmartFrame Array Neuro Navigation System...
The following slide deck was published by ClearPoint Neuro, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: ClearPoint Neuro, Inc. 2021 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. ClearPoint Neuro, Inc. (NASDAQ: CLPT) Q1 2021 Earnings Call May 11, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Conference Call May 11, 2021 4:30 PM ET Company Participants Joe Burnett – Chief Executive Officer Danilo D’Alessandro – Chief Financial Officer Conference Call Participants Andrew D’Silva – B. Riley Securities ...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SOLANA BEACH, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner Aspen Neuroscience, Inc. on use...
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons PR Newswire Aspen Neuroscience Announces MRI-Guided Transplantation Approach for ASPIRO Clinical Trial with the ClearPoint®...